ML22249A127: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot change) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| Line 17: | Line 17: | ||
=Text= | =Text= | ||
{{#Wiki_filter:Chapter 10 - Experimental Facilities Table of Contents | {{#Wiki_filter:Chapter 10 - Experimental Facilities Table of Contents CHAPTER 10 EXPERIMENTAL FACILITIES TABLE OF CONTENTS Section Title Page SHINE Medical Technologies 10-i Rev. 0 10.1 | ||
CHAPTER 10 | |||
EXPERIMENTAL FACILITIES | |||
TABLE OF CONTENTS | |||
Section | |||
10.1 | |||
==SUMMARY== | ==SUMMARY== | ||
| Line 35: | Line 25: | ||
................................................................................................... 10.2-1 | ................................................................................................... 10.2-1 | ||
Chapter 10 - Experimental Facilities List of Tables LIST OF TABLES Number Title SHINE Medical Technologies 10-ii Rev. 0 None | |||
LIST OF TABLES | |||
Number | |||
SHINE Medical Technologies 10-ii Rev. 0 | |||
SHINE Medical Technologies 10- | Chapter 10 - Experimental Facilities List of Figures LIST OF FIGURES Number Title SHINE Medical Technologies 10-iii Rev. 0 None | ||
Chapter 10 - Experimental Facilities Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition SHINE Medical Technologies 10-iv Rev. 0 None | |||
10.1 | Chapter 10 - Experimental Facilities Summary Description SHINE Medical Technologies 10.1-1 Rev. 0 CHAPTER 10 - EXPERIMENTAL FACILITIES 10.1 | ||
==SUMMARY== | ==SUMMARY== | ||
DESCRIPTION | DESCRIPTION The SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: | ||
Format and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors (USNRC, 2012). | |||
The SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing | |||
Format and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors (USNRC, 2012). | |||
SHINE Medical Technologies 10. | Chapter 10 - Experimental Facilities References SHINE Medical Technologies 10.2-1 Rev. 0 | ||
==10.2 REFERENCES== | ==10.2 REFERENCES== | ||
USNRC, 1996. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, | USNRC, 1996. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February1996. | ||
USNRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October17,2012.}} | |||
USNRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, | |||
Latest revision as of 15:52, 27 November 2024
| ML22249A127 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 08/31/2022 |
| From: | SHINE Technologies, SHINE Health. Illuminated |
| To: | Office of Nuclear Reactor Regulation |
| Shared Package | |
| ML22249A148 | List: |
| References | |
| 2022-SMT-0077 | |
| Download: ML22249A127 (6) | |
Text
Chapter 10 - Experimental Facilities Table of Contents CHAPTER 10 EXPERIMENTAL FACILITIES TABLE OF CONTENTS Section Title Page SHINE Medical Technologies 10-i Rev. 0 10.1
SUMMARY
DESCRIPTION............................................................................... 10.1-1
10.2 REFERENCES
................................................................................................... 10.2-1
Chapter 10 - Experimental Facilities List of Tables LIST OF TABLES Number Title SHINE Medical Technologies 10-ii Rev. 0 None
Chapter 10 - Experimental Facilities List of Figures LIST OF FIGURES Number Title SHINE Medical Technologies 10-iii Rev. 0 None
Chapter 10 - Experimental Facilities Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition SHINE Medical Technologies 10-iv Rev. 0 None
Chapter 10 - Experimental Facilities Summary Description SHINE Medical Technologies 10.1-1 Rev. 0 CHAPTER 10 - EXPERIMENTAL FACILITIES 10.1
SUMMARY
DESCRIPTION The SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors:
Format and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors (USNRC, 2012).
Chapter 10 - Experimental Facilities References SHINE Medical Technologies 10.2-1 Rev. 0
10.2 REFERENCES
USNRC, 1996. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February1996.
USNRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October17,2012.